证券代码：000766 证券简称：通化金马 公告编号：2025-25 通化金马药业集团股份有限公司 第十一届董事会2025年第六次临时会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、通化金马药业集团股份有限公司第十一届董事会2025年第六次临时会议 通知于2025年5月29日以微信、电子邮件形式送达全体董事。 2、2025年5月30日上午9时30分在公司七楼会议室以现场和通讯方式召开。 3、会议应到董事9人，实到董事9人。 4、会议由董事长张玉富先生主持。监事会成员及部分高管人员列席了本次 会议。 5、本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性文 件和公司章程的规定。 二、董事会会议审议情况 1、审议并通过《关于修改〈公司章程〉的议案》 根据《公司法》《证券法》《上市公司章程指引（2025 年修订）》及中国证 券监督管理委员会发布的《关于新<公司法>配套制度规则实施相关过渡安排》 等相关法律法规、规范性文件的最新规定，结合公司实际，对《公司章程》进 行修改和完善。具体修改内容详见公司同日披露的《关于修 ...

Group 1: Financial Performance and Debt Management - The company aims to gradually reduce its high debt ratio as its operational stability and profitability improve [2] - The company has not distributed dividends for 20 years, and future dividend distribution will depend on legal regulations and company policies [3] Group 2: New Drug Development and Market Potential - The new drug, HuPo BaTian Nian An Dian Pian, is designed to meet the needs of over 300 million elderly patients in China suffering from Alzheimer's disease [2] - The production system is built according to GMP standards, ensuring that it can meet domestic demand for Alzheimer's medication upon approval [4] - The drug has received acceptance for its listing application from the National Medical Products Administration, entering the review phase [3][5] Group 3: Competitive Landscape and Pricing Strategy - The company is aware of competitive products like Lecanemab and Galantamine, and is strategizing on pricing and market entry for its new drug [3] - The company emphasizes that its new drug offers significant patient benefits without increasing safety risks compared to existing treatments [8] Group 4: Intellectual Property and Regulatory Compliance - The new drug has received patent protection in multiple countries, including Japan and 15 European nations, with a U.S. patent expected by September 2024 [4] - The review process for the new drug is proceeding normally, and the company is committed to timely disclosures regarding its progress [6][7] Group 5: Future Outlook and Strategic Plans - The company plans to enhance its innovation capabilities and adjust its product structure to improve revenue growth [7] - The new drug is expected to significantly enhance the company's profitability once it is commercialized [8]

为进一步加强与投资者的互动交流，通化金马药业集团股份有限公司（以下 简称"公司"）将参加由吉林省证券业协会、深圳市全景网络有限公司共同举办 的"2025 年吉林辖区上市公司投资者网上集体接待日活动"，现将有关事项公告 如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net）；或关注微信公众号（名称：全景财经）；或下载全景路 演 APP,参与本次互动交流。活动时间为 2025 年 5 月 27 日（周二）15:00-16:30。 届时公司董事长、总经理张玉富先生，财务负责人、副总经理于军先生，独 立董事吕桂霞女士，董事会秘书贾伟林先生将通过网络在线问答互动的形式，就 公司 2024 年度业绩、公司治理、发展战略、经营状况等投资者关心的问题，与 投资者进行沟通与交流，欢迎广大投资者踊跃参与！ 关于参加 2025 年吉林辖区上市公司投资者 证券代码：000766 证券简称：通化金马 公告编号：2025-24 网上集体接待日活动的公告 通化金马药业集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 通 ...

Summary of Key Points Core Viewpoint - As of May 16, the total market financing balance decreased to 1.79 trillion yuan, indicating a slight reduction in investor activity in the market [1]. Company and Industry Analysis - The financing balance in the Shanghai market was 907.43 billion yuan, down by 0.92 billion yuan, while the Shenzhen market's balance was 882.06 billion yuan, also down by 0.92 billion yuan. The North Exchange's financing balance decreased to 5.38 billion yuan, down by 0.038 billion yuan [1]. - On May 16, a total of 1,712 stocks received net financing purchases, with 257 stocks having net purchases exceeding 10 million yuan. Notably, 22 stocks had net purchases over 50 million yuan [1]. - The top three stocks by net financing purchases on May 16 were: - China Merchants Bank: 170.42 million yuan - Tonghua Golden Horse: 167.08 million yuan - China Ping An: 136.61 million yuan [2]. - The industries with the highest concentration of stocks receiving net financing purchases over 50 million yuan included automotive, basic chemicals, and food and beverage, each with three stocks listed [1]. - The average ratio of financing balance to circulating market value for stocks with significant net purchases was 4.01%, with Dongtu Technology having the highest ratio at 9.79% [2]. - The financing net purchase rankings on May 16 highlighted several stocks, including: - Dongtu Technology: 8.04 million yuan, 7.58% increase - Tonghua Golden Horse: 16.71 million yuan, 2.45% increase - BYD: 9.85 million yuan, 3.28% increase [2][3].

截至5月12日收盘，创新药概念下跌0.60%，位居概念板块跌幅榜前列，板块内，迈威生物、百济神 州、泽璟制药等跌幅居前，股价上涨的有76只，涨幅居前的有通化金马、新开源、*ST赛隆等，分别上 涨6.84%、6.25%、5.01%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 中船系 | 6.55 | 重组蛋白 | -0.94 | | 成飞概念 | 5.77 | 代糖概念 | -0.82 | | 军工信息化 | 4.28 | 转基因 | -0.77 | | 同花顺果指数 | 4.17 | 创新药 | -0.60 | | 国产航母 | 3.73 | 粮食概念 | -0.60 | | 军民融合 | 3.69 | 玉米 | -0.59 | | 航空发动机 | 3.42 | 大豆 | -0.45 | | 人形机器人 | 3.20 | 农业种植 | -0.31 | | 减速器 | 3.20 | 生物质能发电 | -0.28 | | 军工 | 3.15 | 减肥药 | -0.24 | 资金面上看，今日创新药概念板块获主 ...

| | 能 | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 600732 | 爱旭股 份 | 8.18 | 3.60 | 10.90 | 11.37 | 4.31 | | 000766 | 通化金 马 | 6.49 | 6.47 | 17.78 | 18.53 | 4.22 | （文章来源：证券时报网） 5月12日突破五日均线个股乖离率排名 | 证券代 | 证券简 | 今日涨跌幅 | 今日换手率 | 五日均线 | 最新价 | 乖离率 | | --- | --- | --- | --- | --- | --- | --- | | 码 | 称 | （%） | （%） | （元） | （元） | （%） | | 430425 | 乐创技 术 | 19.85 | 20.17 | 33.18 | 37.55 | 13.16 | | 300726 | 宏达电 子 | 13.09 | 13.15 | 35.76 | 38.97 | 8.99 | | 301325 | 曼恩斯 特 | 12.30 | 18.07 | 54.71 | 59.09 | 8.01 ...

Summary of Key Points Core Viewpoint - As of May 6, the total market financing balance reached 1.79 trillion yuan, indicating an increase of 143.81 billion yuan from the previous trading day, with notable contributions from both the Shanghai and Shenzhen stock exchanges [1]. Financing Balances - Shanghai stock exchange financing balance: 908.24 billion yuan, up by 59.40 billion yuan - Shenzhen stock exchange financing balance: 876.71 billion yuan, up by 83.55 billion yuan - Beijing Stock Exchange financing balance: 5.12 billion yuan, up by 86.21 million yuan [1]. Individual Stock Performance - On May 6, 2,239 stocks received net financing purchases, with 566 stocks having net purchases exceeding 10 million yuan, and 21 stocks exceeding 100 million yuan [1]. - Leading net purchases included: - Luxshare Precision: 228 million yuan - Runhe Software: 212 million yuan - Changshan Beiming: 199 million yuan - Other notable stocks: Inspur Information, Sichuan Changhong, and Dongfang Caifu [1][2]. Industry Concentration - The industries with the highest concentration of stocks receiving net financing purchases over 100 million yuan included: - Computer: 5 stocks - Non-ferrous metals: 3 stocks - Electronics: 3 stocks [1]. Financing Balance to Market Value Ratio - The average ratio of financing balance to circulating market value for stocks with significant net purchases was 4.78% - Stocks with the highest ratios included: - Hanyu Group: 9.63% - Guanghetong: 8.53% - Dongfang Caifu: 7.51% - Runhe Software: 7.49% [2][3]. Notable Stock Data - Top net purchases on May 6 included: - Luxshare Precision: 3.11% increase, net purchase of 227.62 million yuan - Runhe Software: 9.55% increase, net purchase of 212.02 million yuan - Changshan Beiming: 10.02% increase, net purchase of 198.69 million yuan - Other significant stocks included Inspur Information, Sichuan Changhong, and Dongfang Caifu [2][3].

Core Points - The CSI 1000 Quality Index has shown a decline of 8.35% over the past month, an increase of 1.30% over the last three months, and a year-to-date decrease of 1.62% [1] - The index is composed of 100 listed companies selected from the CSI 1000 Index based on their operational stability, profitability, and quality metrics [1] - The top ten weighted companies in the CSI 1000 Quality Index include Yuxin Technology (3.39%), Dataport (3.21%), Tonghua Jinma (3.11%), and others [1] Industry Composition - The industry distribution of the CSI 1000 Quality Index shows that the healthcare sector accounts for 24.45%, industrials for 18.35%, and information technology for 14.63% [2] - Other sectors include consumer discretionary (9.77%), financials (9.69%), communication services (8.13%), and materials (5.64%) [2] - The index undergoes semi-annual adjustments, with changes implemented on the next trading day following the second Friday of June and December [2]

Group 1 - As of April 18, the total market financing balance is 1.79 trillion yuan, a decrease of 6.28 billion yuan from the previous trading day, marking three consecutive days of decline [1] - The financing balance for the Shanghai Stock Exchange is 913.65 billion yuan, down by 3.34 billion yuan; for the Shenzhen Stock Exchange, it is 873.79 billion yuan, down by 2.93 billion yuan; and for the Beijing Stock Exchange, it is 5.28 billion yuan, down by 19.61 million yuan [1] - On April 18, a total of 1,349 stocks received net financing purchases, with 158 stocks having net purchases exceeding 10 million yuan, and 10 stocks with net purchases over 50 million yuan [1] Group 2 - The top net financing purchase on April 18 was for Tuowei Information, with a net purchase amount of 168 million yuan, followed by Hanwujing and Wo Ai Wo Jia with net purchases of 156 million yuan and 76.97 million yuan, respectively [1] - In terms of industry, the stocks with net purchases exceeding 50 million yuan are concentrated in the computer, pharmaceutical, and non-ferrous metal sectors, with two stocks from each industry on the list [1] - Among the stocks with significant net purchases, 8 are from the main board, 1 from the ChiNext board, and 1 from the Sci-Tech Innovation board [1] Group 3 - The average ratio of financing balance to circulating market value for stocks with large net purchases is 3.65%, with ZTE Communications having the highest ratio at 5.88% [2] - Other stocks with high financing balance ratios include Tonghua Golden Horse, Wo Ai Wo Jia, and Tuowei Information, with ratios of 5.33%, 5.32%, and 5.01%, respectively [2] - The financing net purchase rankings for April 18 show that Tuowei Information increased by 3.17%, while Hanwujing decreased by 1.10% [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000766 证券简称：通化金马 公告编号：2025-23 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经审计 □是 √否 一、主要财务数据 单位：元 ■ 其他符合非经常性损益定义的损益项目的具体情况 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ （二） 非经常性损益项目和金额 √适用 □不适用 ■ 二、股东信息 （一） 普通股股东总数和表决权恢复的优先股股东数量及前十名股东持股情况表 ■ □适用 √不适用 公司不存在其他符合非经常性损益定义的损益项目的具体情况。 将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》中列举的非经常性损益项目界 定为 ...